Skip to content

Cancer Drug Parity Act of 2025

Health

119-hr4101 — Cancer Drug Parity Act of 2025. Sponsored by Rep. Grothman, Glenn [R-WI-6]. Introduced 2025-06-24. House bill. 119th Congress. Latest action: Referred to the House Committee on Education and Workforce.

119-hr4101 119th Congress House
Sponsor
Rep. Grothman, Glenn [R-WI-6] (R), WI
Introduced
2025-06-24
Committees
Education and Workforce Committee
Latest Action
Referred to the House Committee on Education and Workforce.

No roll-call vote data available for this bill.

Similar Bills

  • 118-hr6301 — Cancer Drug Parity Act of 2023 82% match 118th Congress
  • 118-s2039 — Cancer Drug Parity Act of 2023 67% match 118th Congress
  • 119-hr1018 — INSTRUCT Act of 2025 52% match
  • 119-hr957 — Parity Enforcement Act of 2025 49% match
  • 119-hr2275 — SCHOOL Act of 2025 49% match
Investigate this bill → Beneficiary scoring, topic classification, and fiscal analysis